Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × Steroids × Clear all

Phase

Phase 3 4 Phase 1 3 Phase NA 2 Phase 2 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 21 Metformin 13 pembrolizumab 10 Biopsy 10 Radiotherapy 8 Cyclophosphamide 7 gallium 68 PSMA-11 6 Sirolimus 6 Nivolumab 6 Fluorouracil 6 Bevacizumab 6 Rituximab 5 Radiation 5 Granulocyte Colony-Stimulating Factor 5 Fluorodeoxyglucose F18 5 Etoposide 5 Temozolomide 4 Radiosurgery 4 Methotrexate 4 Letrozole 4 Filgrastim 4 Doxorubicin 4 Cisplatin 4 Aspirin 4 poly ICLC 3 olaparib 3 fluciclovine F-18 3 durvalumab 3 Vitamin D 3 Vincristine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04019834 2022-08-03

RELIEF

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡